M&A / Deals Roche buys AI-powered diagnostics player PathAI PharmaphorumRoche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.Read full story pharminent May 7, 2026 (Last updated: May 7, 2026) Pharmaphorum Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: UCB and Cancer Research UK form expanded alliance to advance novel cancer therapiesNext: Bayer plans filings for cardiac amyloidosis imaging agent Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
